Assignee
NEURO BIO LTD
GB·9 granted patents·6 pending applications·16 citations·filing 2014–2022
Top patents by PatentIndex Score
15 records- 0186US10053677B2Neurodegenerative disordersNEURO BIO LTD·Filed 2014·Granted Aug 21, 2018·7 cites·6 claims
- 0283US10954306B2Antibody that recognises the T14 peptide of AChENEURO BIO LTD·Filed 2016·Granted Mar 23, 2021·3 cites·6 claims
- 0381US11091747B2Neurodegenerative disordersNEURO BIO LTD·Filed 2018·Granted Aug 17, 2021·2 cites·17 claims
- 0476US10729749B2Neurodegenerative disordersNEURO BIO LTD·Filed 2015·Granted Aug 4, 2020·3 cites·10 claims
- 0575US12139729B2Neurodegenerative disordersNEURO BIO LTD·Filed 2021·Granted Nov 12, 2024·0 cites·1 claims
- 0669US10441638B2Cyclic acetylcholinesterase c-terminal peptide in the treatment or prevention of cancer or metastasisNEURO BIO LTD·Filed 2015·Granted Oct 15, 2019·1 cites·3 claims
- 0763US11033609B2Cyclic acetylcholinesterase C-terminal peptide in the treatment or prevention of cancer or metastasisNEURO BIO LTD·Filed 2019·Granted Jun 15, 2021·0 cites·2 claims
- 0861US2024369578A1Peptide t14 for braak stagingNEURO BIO LTD·Filed 2022·Application pending·0 cites
- 0957US2024207373A1Cyclic peptides from the c-terminus of acetylcholinesterase for treatment of skin disorders and for cosmetical useNEURO BIO LTD·Filed 2021·Application pending·0 cites
- 1057US2024058424A1Nbp-14 for treating alzheimer's associated with down's syndromeNEURO BIO LTD·Filed 2021·Application pending·0 cites
- 1155US2025277798A1Skin biomarkerNEURO BIO LTD·Filed 2022·Application pending·0 cites
- 1251US2022361462A1Animal model for neurodegenerative disordersNEURO BIO LTD·Filed 2020·Application pending·0 cites
- 1345US11287416B2CancerNEURO BIO LTD·Filed 2017·Granted Mar 29, 2022·0 cites·15 claims
- 1438US2020271673A1BiomarkerNEURO-BIO LTD·Filed 2018·Application pending·0 cites
- 1532US11939398B2Modified peptides for use in treating neurodegenerative disordersNEURO BIO LTD·Filed 2017·Granted Mar 26, 2024·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →